Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus.
Anterior nares cultures from 664 hospital personnel identified 165 (24.8%) as carriers of Staphylococcus aureus. Persistent carriers (17.8%) were identified and randomly assigned to one of four treatment groups: rifampin (600 mg once a day for 5 days), bacitracin ointment (topically applied three ti...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1984
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185544/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732212/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.422 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|